BeOne Medicines Reports Improved Survival in Phase 3 Cancer Study
The company said a combination treatment improved overall survival among patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.